ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $214,960 | -36.5% | 8,000 | -15.8% | 0.04% | -37.9% |
| Q2 2023 | $338,770 | -12.1% | 9,500 | 0.0% | 0.06% | -23.7% |
| Q4 2022 | $385,320 | +50.5% | 9,500 | +22.6% | 0.08% | +46.2% |
| Q3 2022 | $256,000 | -3.0% | 7,750 | +3.3% | 0.05% | 0.0% |
| Q2 2022 | $264,000 | -4.3% | 7,500 | +25.0% | 0.05% | +10.6% |
| Q1 2022 | $276,000 | -30.7% | 6,000 | 0.0% | 0.05% | -27.7% |
| Q4 2021 | $398,000 | +6.1% | 6,000 | 0.0% | 0.06% | -4.4% |
| Q3 2021 | $375,000 | +19.0% | 6,000 | +57.9% | 0.07% | +19.3% |
| Q2 2021 | $315,000 | +25.0% | 3,800 | 0.0% | 0.06% | +16.3% |
| Q1 2021 | $252,000 | -13.7% | 3,800 | 0.0% | 0.05% | -19.7% |
| Q4 2020 | $292,000 | +21.2% | 3,800 | 0.0% | 0.06% | -6.2% |
| Q4 2019 | $241,000 | – | 3,800 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,303 | $54,386,000 | 28.54% |
| JOHNSON & JOHNSON | 3,260,869 | $216,196,000 | 24.61% |
| ACT CAPITAL MANAGEMENT, LLC | 210,500 | $13,956,000 | 10.09% |
| Aquilo Capital Management, LLC | 700,426 | $46,438,000 | 5.27% |
| WEALTH EFFECTS LLC | 145,960 | $9,677,000 | 4.02% |
| Evolutionary Tree Capital Management, LLC | 115,580 | $7,663,000 | 3.68% |
| ACUTA CAPITAL PARTNERS, LLC | 105,500 | $6,995,000 | 2.94% |
| Privium Fund Management B.V. | 204,393 | $13,766,000 | 2.73% |
| L1 Capital Pty Ltd | 292,735 | $19,408,000 | 2.24% |
| Avidity Partners Management LP | 875,000 | $58,013,000 | 1.23% |